Wuhan YZY Biopharma Co Ltd Sustainability Reports
A biotechnology company that develops bispecific antibody-based therapies for the treatment of cancer, cancer-associated complications, and ophthalmologic diseases.
Sector: Manufacturing
Country: China
Exchange: Hong Kong Stock Exchange
FIGI: BBG01J9MPDL0
5 reports from 2023 to 2024